Allergan Increases Sales

Posted by on May 1, 2010 in Allergan | 0 comments Things are looking good for Allergan, Inc., the makers of BOTOX®. For the quarter ending March 31, 2010, the pharmaceutical company reported total product net sales were $1,105.8 million, showing an increase of 11.2% over the first quarter in 2009. Perhaps sales were helped by the FDA approval of BOTOX®for another therapeutic purpose on March 9, 2010: to treat adults with upper limb spasticity...
read more